TERN
Terns Pharmaceuticals, Inc.
$52.95
+0.00 (+0.00%)
At close · May 7
Market Cap
$6.12B
Shares
115,521,157
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-01-15 | AMY BURROUGHS | Director, Officer | 97,915 | 2026-01-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-04 | JILL QUIGLEY | Director | 24,520 | 2025-11-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-06 | MARK J VIGNOLA | Officer | 9,059 | 2025-01-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-06 | JILL QUIGLEY | Director | 8,760 | 2025-01-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-09-10 | MARK J VIGNOLA | Officer | 10,000 | 2024-09-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-09-10 | SEOKHO BRYAN YOON | Officer | 10,000 | 2024-09-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-09-09 | JILL QUIGLEY | Officer | 8,857 | 2024-09-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-07-15 | OrbiMed Private Investments VII, LP | Director, Shareholder | 976,800 | 2024-07-15 | TD Cowen |
| 2024-07-15 | OrbiMed Genesis Master Fund, LP | Director, Shareholder | 152,400 | 2024-07-15 | TD Cowen |
| 2024-07-15 | JILL QUIGLEY | Director, Officer | 32,000 | 2024-07-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-07-15 | OrbiMed Asia Partners III, LP | Director, Shareholder | 131,700 | 2024-07-15 | TD Cowen |
| 2024-04-03 | Vivo Capital Fund VIII, L.P. | Director | 39,416 | 2024-04-03 | Cowen and Company, LLC |
| 2024-04-03 | Vivo Capital Surplus Fund VIII, L.P. | Director | 5,443 | 2024-04-03 | Cowen and Company, LLC |
| 2024-04-03 | Vivo Opportunity Fund Holdings, L.P. | Director | 136,258 | 2024-04-03 | Cowen and Company, LLC |
| 2024-04-01 | Vivo Capital Surplus Fund VIII, L.P. | Director | 8,832 | 2024-04-01 | Cowen and Company, LLC |
| 2024-04-01 | Vivo Opportunity Fund Holdings, L.P. | Director | 221,095 | 2024-04-01 | Cowen and Company, LLC |
| 2024-04-01 | Vivo Capital Fund VIII, L.P. | Director | 63,956 | 2024-04-01 | Cowen and Company, LLC |
Showing 1–17 of 17 filings